RATIONALE: Dysfunctional reward processing has been proposed as a main deficit in attention-deficit/hyperactivity disorder (ADHD), which could be modulated by treatment with methylphenidate (MPH). OBJECTIVES: We examined differences in reward processing in adulthood (independent of actual ADHD) depending on MPH treatment during childhood. METHODS: Eleven males with childhood ADHD treated with MPH, 12 drug-naïve males with childhood ADHD, and 12 controls matched by age, handedness, and smoking behavior were studied drug-free using functional magnetic resonance imaging. BOLD-responses were compared during a monetary incentive delay task using an ANOVA design focusing on the ventral striatum during anticipation and the orbitofrontal cortex during outcome. RESULTS: Controls, drug-naïve, and treated subjects did not differ significantly in their activations in the ventral striatum and orbitofrontal cortex. Explorative analyses revealed decreased insula activation during outcome of loss avoidance in drug-naïve subjects in comparison to both groups, while treated subjects did not differ from controls. Insula activation correlated significantly positive with harm avoidance in the treated group. Furthermore, comparing subjects with actual ADHD symptoms, remitters and controls we observed decreased putamen activition in ADHD persisters. CONCLUSIONS: Basal ganglia reward processing seemed to be unrelated to MPH pretreatment, but was related to remission. On the other hand, the revealed differences between treated and drug-naïve subjects with childhood ADHD, i.e., in the insula, give evidence for more pronounced abnormal activation in reward-associated brain regions in untreated subjects with childhood ADHD and underpin the need of prospective studies on long-term effects of psychostimulant treatment.
RATIONALE: Dysfunctional reward processing has been proposed as a main deficit in attention-deficit/hyperactivity disorder (ADHD), which could be modulated by treatment with methylphenidate (MPH). OBJECTIVES: We examined differences in reward processing in adulthood (independent of actual ADHD) depending on MPH treatment during childhood. METHODS: Eleven males with childhood ADHD treated with MPH, 12 drug-naïve males with childhood ADHD, and 12 controls matched by age, handedness, and smoking behavior were studied drug-free using functional magnetic resonance imaging. BOLD-responses were compared during a monetary incentive delay task using an ANOVA design focusing on the ventral striatum during anticipation and the orbitofrontal cortex during outcome. RESULTS: Controls, drug-naïve, and treated subjects did not differ significantly in their activations in the ventral striatum and orbitofrontal cortex. Explorative analyses revealed decreased insula activation during outcome of loss avoidance in drug-naïve subjects in comparison to both groups, while treated subjects did not differ from controls. Insula activation correlated significantly positive with harm avoidance in the treated group. Furthermore, comparing subjects with actual ADHD symptoms, remitters and controls we observed decreased putamen activition in ADHD persisters. CONCLUSIONS: Basal ganglia reward processing seemed to be unrelated to MPH pretreatment, but was related to remission. On the other hand, the revealed differences between treated and drug-naïve subjects with childhood ADHD, i.e., in the insula, give evidence for more pronounced abnormal activation in reward-associated brain regions in untreated subjects with childhood ADHD and underpin the need of prospective studies on long-term effects of psychostimulant treatment.
Authors: Marcela Henriquez-Henriquez; Francisco Zamorano-Mendieta; Francisco Rothhammer-Engel; Francisco Aboitiz Journal: Rev Neurol Date: 2010 Jan 16-31 Impact factor: 0.870
Authors: Monique Ernst; Alane S Kimes; Edythe D London; John A Matochik; Dana Eldreth; Satya Tata; Carlo Contoreggi; Michelle Leff; Karen Bolla Journal: Am J Psychiatry Date: 2003-06 Impact factor: 18.112
Authors: Andrea G Ludolph; Jan Kassubek; Klaus Schmeck; Cornelia Glaser; Arthur Wunderlich; Andreas K Buck; Sven N Reske; Joerg M Fegert; Felix M Mottaghy Journal: Neuroimage Date: 2008-02-29 Impact factor: 6.556
Authors: Yannis Paloyelis; Mitul A Mehta; Stephen V Faraone; Philip Asherson; Jonna Kuntsi Journal: J Am Acad Child Adolesc Psychiatry Date: 2012-06-05 Impact factor: 8.829
Authors: Thomas J Spencer; Ariel Brown; Larry J Seidman; Eve M Valera; Nikos Makris; Alexandra Lomedico; Stephen V Faraone; Joseph Biederman Journal: J Clin Psychiatry Date: 2013-09 Impact factor: 4.384
Authors: Iliyan Ivanov; Xun Liu; Kurt Shulz; Jin Fan; Edythe London; Karl Friston; Jeffrey M Halperin; Jeffrey H Newcorn Journal: Psychiatry Res Date: 2012-03-03 Impact factor: 3.222